JR
Jayshri Rajshekhar Hiremath
About Jayshri Rajshekhar Hiremath
Data last updated:
Jayshri Rajshekhar Hiremath is an Additional Director at Incorporeal Pharma Private Limited (since 2022). The company operates in Trading. Incorporeal Pharma Private Limited reported revenue of ₹98.2 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Incorporeal Pharma Private Limited U51909PN2021PTC205424 | Additional Director | 27 Nov 2022 | 2021 | ₹98.2 Lakh (FY 2025) | Active |
Board colleagues of Jayshri Rajshekhar Hiremath
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Ashok Shetti | 09369741 | Incorporeal Pharma Private Limited | Director |
| Aniket Sangameshwarkar | 09369742 | Incorporeal Pharma Private Limited | Director |
| Dineshkumar Haribhau Dandekar | 08844683 | Incorporeal Pharma Private Limited | Additional Director |
| Sachin Bhagwant Gondhale | 09369740 | Incorporeal Pharma Private Limited | Director |
| Sharad Aannaso Patil | 10284722 | Incorporeal Pharma Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jayshri Rajshekhar Hiremath
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jayshri Rajshekhar Hiremath
Jayshri Rajshekhar Hiremath currently holds 1 directorship: Incorporeal Pharma Private Limited (Additional Director, since 27 Nov 2022, revenue ₹98.2 Lakh (FY 2025)).
Jayshri Rajshekhar Hiremath was first appointed on 27 Nov 2022 as Additional Director at Incorporeal Pharma Private Limited.
The current boards of Jayshri Rajshekhar Hiremath's companies include Amit Ashok Shetti (Incorporeal Pharma Private Limited), Aniket Sangameshwarkar (Incorporeal Pharma Private Limited), Dineshkumar Haribhau Dandekar (Incorporeal Pharma Private Limited), Sachin Bhagwant Gondhale (Incorporeal Pharma Private Limited), Sharad Aannaso Patil (Incorporeal Pharma Private Limited).